Eating Disorders News and Research

Latest Eating Disorders News and Research

Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoints

Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.

12 Mar 2010

Study explores incidence of eating disorders among type 1 diabetic patients

Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said.

12 Mar 2010

Women who participate in sorority rush display body dissatisfaction and eating disorder behaviors

Undergraduate women who join a sorority are more likely to judge their own bodies from an outsider's perspective (known as self-objectification) and display higher levels of bulimic attitudes and behaviors than those who do not take part in the sorority's recruitment process.

4 Mar 2010

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.

1 Mar 2010

Aesthetic sports sanction behaviors more consistent with eating disorders than healthy living

The control and perfectionism that set Olympic athletes apart from their peers at lower levels of competition often have a darker side, according to Kimberly Dennis, M.D., a leading psychiatrist specializing in eating disorder treatment.

22 Feb 2010

Lucile Packard Children’s Hospital gearing up for National Eating Disorders Awareness Week

Lucile Packard Children’s Hospital at Stanford is gearing up for National Eating Disorders Awareness Week, Feb. 21 – 27. The hospital's Comprehensive Eating Disorders Program is reaching out to Bay Area families to enhance knowledge of anorexia nervosa, bulimia nervosa and related diagnoses.

19 Feb 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

In a new study of treatment-experienced HIV-1-infected adults with no PREZISTA® (darunavir) resistance-associated mutations (RAMs), 72 percent of patients in the PREZISTA/ritonavir (r) (800/100 mg) once-daily arm achieved undetectable viral loads (<50 copies/mL) compared with 71 percent of patients in the PREZISTA/r (600/100 mg) twice-daily arm. The study met its primary objective of non-inferiority. These data from the Phase 3b ODIN study were presented today at CROI 2010, the 17th Conference on Retroviruses and Opportunistic Infections, in San Francisco.

18 Feb 2010

APA releases proposed draft diagnostic criteria for DSM-5

The American Psychiatric Association today released the proposed draft diagnostic criteria for the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM). The draft criteria represent content changes under consideration for DSM, which is the standard classification of mental disorders used by mental health and other health professionals, and is used for diagnostic and research purposes.

10 Feb 2010

Study reveals people with anorexia nervosa have increased fat content in their bone marrow

People with anorexia nervosa, paradoxically, have strikingly high levels of fat within their bone marrow, report researchers at Children's Hospital Boston. Their findings, based on MRI imaging of the knees of 20 girls with anorexia and 20 healthy girls of the same age, appear in the February issue of the Journal of Bone and Mineral Research.

9 Feb 2010

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Tibotec Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies.

29 Jan 2010

Blood sugar levels link decision making to metabolic cues

Would you choose to receive a small amount of money today or a larger sum next month? We know that it is worth it to wait longer for a larger reward, but sometimes the temptation for the smaller, immediate reward becomes too great and we simply cannot resist it. Selecting the immediate reward is known as "future discounting" and often suggests a lack of self-control.

27 Jan 2010

Pfizer reports final results from randomized Phase 3 trial of Sutent

Pfizer Inc. today announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas.

23 Jan 2010

Tips to identify signs of eating disorders

It's estimated that one-third of Americans made a New Year's resolution to lose weight this year. Though these dieting individuals may have healthy intentions, they could be putting themselves at risk for an eating disorder, warns Eating Recovery Center (www.eatingrecoverycenter.com), a licensed and Joint Commission accredited behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders.

22 Jan 2010

Psychotherapy may prevent obesity in teenage girls

Girls who undertook IPT were more likely to stabilize or reduce their BMI than those who received the health education classes. BMI is a measure of body weight corrected for height and, when adjusted for age and sex, is used to determine appropriate weight gain in growing children and teens.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

WDI utilizes DXA analysis for fitness and weight management programs

Women's Digital Imaging of Ridgewood (WDI), has begun using Dual Energy X-ray Absorptiometry (DXA), a technology developed to screen for osteoporosis (bone loss), to measure body fat in patients who want a more accurate method of establishing goals and measuring results for weight management and fitness programs.

4 Jan 2010

Food addiction remains largely ignored but can be easily overcome, says psychologist

As holiday parties give way to New Year's resolutions, rehabs across the country become inundated, making early January one of the industry's busiest times of the year.

31 Dec 2009

Several maladaptive eating behaviors can affect women, says new study

Several maladaptive eating behaviors, beyond anorexia, can affect women. Indeed, some 10 to 15 percent of women have maladaptive eating behaviours and attitudes according to new study from the Universit- de Montr-al and the Douglas Mental Health University Institute published in the International Journal of Eating Disorders.

19 Dec 2009

Interpersonal Psychotherapy may hold hope for teenager girls at risk of obesity

A team of scientists at the Uniformed Services University of the Health Sciences and the National Institutes of Health have piloted psychotherapy treatment to prevent excessive weight gain in teenager girls deemed 'at risk' for obesity.

15 Dec 2009

Pfizer announces results from studies evaluating neratinib

Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2009

Eating Disorders News and Research

Latest Eating Disorders News and Research

Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoints

Study explores incidence of eating disorders among type 1 diabetic patients

Women who participate in sorority rush display body dissatisfaction and eating disorder behaviors

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Aesthetic sports sanction behaviors more consistent with eating disorders than healthy living

Lucile Packard Children’s Hospital gearing up for National Eating Disorders Awareness Week

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

APA releases proposed draft diagnostic criteria for DSM-5

Study reveals people with anorexia nervosa have increased fat content in their bone marrow

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Blood sugar levels link decision making to metabolic cues

Pfizer reports final results from randomized Phase 3 trial of Sutent

Tips to identify signs of eating disorders

Psychotherapy may prevent obesity in teenage girls

VELCADE sNDA receives FDA approval

WDI utilizes DXA analysis for fitness and weight management programs

Food addiction remains largely ignored but can be easily overcome, says psychologist

Several maladaptive eating behaviors can affect women, says new study

Interpersonal Psychotherapy may hold hope for teenager girls at risk of obesity

Pfizer announces results from studies evaluating neratinib

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Eating Disorders News and Research

Latest Eating Disorders News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in